Acrivon Therapeutics (ACRV) Appoints Charles Baum to its Board

Go back to Acrivon Therapeutics (ACRV) Appoints Charles Baum to its Board
(NASDAQ: ACRV) Delayed: 2.02 -0.03 (1.46%)
Previous Close $2.05    52 Week High
Open $2.05    52 Week Low
Day High $2.05    P/E N/A 
Day Low $1.97    EPS
Volume 144,673